Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors

Br J Dermatol. 2024 Aug 14;191(3):465-467. doi: 10.1093/bjd/ljae202.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Drug Eruptions* / epidemiology
  • Drug Eruptions* / etiology
  • Exanthema / chemically induced
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Incidence
  • Male
  • Middle Aged
  • Retrospective Studies
  • Trimethoprim, Sulfamethoxazole Drug Combination* / adverse effects

Substances

  • Immune Checkpoint Inhibitors
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Adrenal Cortex Hormones
  • Glucocorticoids